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Abstract In order to modify the catalytic properties of trypsin,
lysine-188 (S1) of the substrate binding pocket was substituted by
an aromatic amino acid residue (Phe, Tyr, Trp) or by a histidyl
residue. Two other mutants were obtained by displacement or
elimination of the negative charge of aspartic acid-189 (K188D/
D189K and G187W/K188F/D189Y, respectively). The high
affinity inhibitors, like PSTI II and BPTI, behaved as specific
substrates of the trypsin and its mutants. Their inhibiting effect
toward modified trypsins was studied. The bovine inhibitor had a
higher affinity for all tested enzymes than pea inhibitor. The
inhibition constants differed according to the mutations on the
protease.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The current understanding of the physiology and biochem-
istry of nutritional nitrogen shows that some of the peptide
fragments resulting from the action of the digestive tract pro-
teases function not only as suppliers of amino acids to the
organism but also as physiological regulators. It is believed
that several peptides arising from hydrolysis of L-casein have
important physiological functions. Opioid activity was as-
signed by Brantl et al. [1] to peptide fragment 60^66, called
L-casomorphin. The ¢rst 20 residues of L-casein contain phos-
phopeptide binding calcium [2]. Anti-hypertensive activity was
also reported for a L-casein 177^183 peptide [3]. Opiate pep-
tides can also be excised from L-lactoglobulin (L-lactorphin:
residues 102^105) during its hydrolysis by trypsin in vitro [4].
Many dietetic and pharmaceutic uses of milk proteins and
derived peptides were reviewed by Maubois and LeŁonil [5].
Consequently, the study of chemical and/or enzymatic mod-
i¢cations of milk proteins in order to produce such peptides
are especially interesting [6^11]. The search for enzymes with
novel speci¢cities is one of the main goals of protease engi-
neering. The substrate speci¢city di¡erences in serine pro-
teases, such as trypsin, chymotrypsin and elastase, result
from relatively simple structural changes in their substrate
binding site. Several studies were carried out to determine
the crucial role of negative charge of the Asp-189 residue in
binding and catalysis using site-directed mutagenesis [12]. The
study of mutants such as D189K [13], D189S [14], K188D/
D189K [15] and G187W/K188F/D189Y [16] showed that the
presence of a negative charge is essential for a good orienta-
tion of the substrate and e⁄cient catalysis by trypsin. Align-
ments of amino acid sequences revealed that porcine pancre-
atic elastase, ¢ddler crab collagenase and rat anionic trypsin
all have either Lys or Arg in position 188 [17]. However, all
these enzymes present di¡erent speci¢cities. Consequently, the
amino acid in position 188 also plays an important structural
role di¡ering from outright de¢nition of protease speci¢city.
In order to modify the catalytic properties of trypsin, three
mutants were produced by substituting Lys-188 with an aro-
matic amino acid (Phe, Tyr or Trp). These substitutions in-
duce a modi¢cation of electrostatic and hydrophobic interac-
tions in the neighborhood of the Asp-189 residue. The study
of L-casein hydrolysis by these aromatic mutants showed that,
in addition to cleavage of peptide bonds involving Lys or Arg,
new sites of cleavage appeared, involving glutaminyl and as-
paraginyl residues [18].
The substitution of Lys-188 by a histidyl residue created a
chelation site in the substrate binding pocket and allowed the
study of the inhibitory e¡ect of a metal ion (Cu2) [19] on the
catalytic activity of trypsin.
Tryptic inhibitors are often rich in amide residues (Asn,
Gln) and it seemed interesting to study the e¡ect of trypsin
inhibitors on these mutant trypsins and to compare it with the
inhibition of wild-type enzyme.
Serine protease inhibitors are found in the plant and animal
kingdoms. They are classi¢ed into di¡erent families according
to amino acid sequence homology, cysteine number and the
position of the active site. Inhibitors present in plants were
studied extensively because of their antinutritional properties
[20^22] and their protective functions in plants [23^26]. In the
present work two inhibitors belonging to two di¡erent fami-
lies (Kunitz and Bowman-Birk) but displaying competitive
properties toward trypsin [27] were used.
Pisum sativum trypsin inhibitor (PSTI II), taken from win-
ter pea seeds (cv. Frilene), is a member of the Bowman-Birk
family. It is characterized by a low molecular weight (6807
Da), the presence of 14 cysteinyl residues (forming seven di-
sul¢de bridges) and of two distinct binding sites for two di¡er-
ent proteases (trypsin and chymotrypsin) inhibited independ-
ently [28^30] (Fig. 1A). Its three-dimensional structure is
being studied.
Bovine pancreatic trypsin inhibitor (BPTI) belongs to the
Kunitz family. It is characterized by a low molecular weight
(6516 Da), the presence of six cysteinyl residues (forming three
disul¢de bridges) and of a single protease binding site (Fig.
1B). This inhibitor was chosen since its activity and its three-
dimensional structure are well known [31^33].
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2. Materials and methods
Bovine trypsin TPCK-treated (10 000^13 000 U/mg), bovine inhib-
itor (BPTI), succinyl-Ala-Ala-Pro-X-p-nitroanilide (X = Arg or Lys),
4-methylumbelliferyl-p-guanidinobenzoate (MUGB) were from Sigma
Chemical Co.
Pisum sativum inhibitor (PSTI II), puri¢ed according to Ferrasson
[34], was a kind gift from Eric Ferrasson (INRA LBTP, Nantes).
Trypsin mutants were prepared by oligonucleotide-directed muta-
genesis carried out by the method of Kunkel et al. [35], using single-
stranded, uracil-containing DNA templates, as previously described
[19]. Six mutants were studied. K188F, K188Y, K188W and K188H
are the results of single substitutions. Trypsin mutant K188D/D189K
resulted from an inversion of the charge in the substrate binding
pocket. The triple mutant G187W/K188F/D189Y introduced three
aromatic amino acid residues in the substrate binding pocket with
suppression of the negative charge.
2.1. Protein production and puri¢cation
Culture of Escherichia coli strain HB2151 was carried out on Luria
broth medium overnight at 37‡C in the presence of ampicillin (50 mg/
l) and 0.5 mM IPTG to induce expression. Wild-type and mutant
trypsins were secreted in the periplasm space of cells. Periplasmic
extracts were prepared by treatment with lysozyme [36] and were
subsequently dialyzed against 10 mM sodium citrate pH 2.2, at 4‡C
for 24 h. The resulting solution was then applied to a CM-Sepharose
fast-£ow column (2.6 i.d.U30 cm) in a volume equal to the volume of
the column equilibrated with a 0.1 M citric acid, 0.1 M trisodium
citrate, pH 4.0 bu¡er. Fractions containing trypsin were monitored
by the following method. An aliquot of each fraction was mixed with
an equal volume of 2ULaemmli bu¡er [37] lacking 2-mercaptoetha-
nol. The sample was then electrophoresed on a 12.5% polyacrylamide,
1% SDS running gel with a 4.75% polyacrylamide stacking gel. After
electrophoresis, the separating gel was soaked in 2.5% Triton X-100
for 35 min then in a 50 mM Tris-HCl, 20 mM CaCl2, pH 8.0 solution.
This gel was overlaid with an 8% polyacrylamide gel in 40 mM Tris-
HCl, 15 mM CaCl2, pH 8.0 containing 0.1% whole bovine casein. The
‘gel sandwich’ was incubated overnight at 37‡C then dyed with Coo-
massie blue. Trypsin was therefore detected by digestion of the casein
leading to a lack of coloration at a level corresponding to the molec-
ular weight of this protein. The pH of the fractions from chromatog-
raphy on CM-Sepharose and containing trypsin was adjusted at 6.0
with 6 N NaOH. The solution was applied to a benzamidine-Sephar-
ose column (1.6 i.d.U4.0 cm) and chromatography carried out in 50
mM Tris-HCl, 20 mM CaCl2, pH 8.0. After complete elution of un-
bound proteins as indicated by the return of the absorbance to its
initial value, bound trypsin was eluted with 10 mM HCl. All enzyme
puri¢cations were carried out at 4‡C.
2.2. Active site titration
A stock (10 mM) solution of MUGB was prepared in N-methyl-
pyrrolod-2-one. The stock solution was diluted 1/10 000 in 10 mM
HCl. 10 Wl of the dilution was added to 980 Wl of a 50 mM Tris-
HCl, 100 mM NaCl, 20 mM CaCl2, pH 8.0 bu¡er in a £uorometer
cuvette. Then, 10 Wl of bovine trypsin (0.01 M) was added to the
solution. Fluorescence was measured on a SLM4800 Aminco with
an excitation wavelength of 365 nm and an emission wavelength of
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Fig. 1. A: Primary structure of the Pisum sativum inhibitor PSTI II [27]. B: Primary structure of the bovine inhibitor BPTI [48].
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445 nm [38]. Titration was performed at 20‡C and the reaction was
followed for 10 min. A standard scale was made with bovine trypsin
of known concentration ([E]I[S]) and the MUGB solution. During
active site titration of trypsin mutants, 100 Wl of enzyme solution was
added to 890 Wl of 50 mM Tris-HCl, 100 mM NaCl, 20 mM CaCl2,
pH 8.0 bu¡er and to 10 Wl of MUGB (0.1 WM).
2.3. Molecular modelling
Molecular modelling studies were carried out on Silicon Graphics
computers with Biosym/Molecular Simulation packages. Molecular
display and energy minimizations were performed with Insight II
and Discover packages, respectively. Two force ¢elds were used at
di¡erent stages of the calculations. The Amber force ¢eld was initially
employed for energy measurements and in minimization procedures.
The initial structure of trypsin was extracted from X-ray data of its
complex with ecotin [39] accessible from the Protein Data Bank.
Although two segments are missing in this structure (114^117 and
146^148), this trypsin structure was chosen as the starting geometry
because of its high crystallographic resolution (1.8 Aî ). The missing
residues do not signi¢cantly perturb the meaning of this molecular
modelling study since all energy calculations were performed by keep-
ing ¢xed the backbone of heavy atoms not involved in the binding
pocket contour (essentially residues 182^195 and 213^228).
The mutant model was obtained by replacing Lys-188 with Phe,
Tyr, Trp or His but also by inversion of Lys-188 and Asp-189.
Wild-type and mutant geometries were optimized with the same pro-
tocol. A ¢rst minimization for 1000 iterations ¢xing the backbone
heavy atoms was followed by a second minimization step for 3000
iterations ¢xing all heavy atoms except those involved in the substrate
binding pocket.
2.4. Hydrolysis of synthetic substrates by wild-type and mutant
trypsins, in the presence or absence of inhibitors
Succinyl-Ala-Ala-Pro-Arg-pNA and succinyl-Ala-Ala-Pro-Lys-
pNA were used for the kinetics studies. Synthetic substrates and in-
hibitors were dissolved in 100 mM Tris-HCl, 20 mM CaCl2, pH 8.0
bu¡er. Bovine trypsin was previously solubilized in 10 mM HCl and
the recombinant trypsins were conserved at pH 2.0 and 320‡C. The
cleavage of p-nitroanilide derivatives was measured by following p-
nitroaniline released at 405 nm with a Varian Cary 13E spectropho-
tometer. During the testing of the proteolytic activity inhibition of
each inhibitor (BPTI and PSTI II), enzymes (various concentrations
according to mutants and substrate) were preincubated for 4 min at
37‡C and pH 8.0 with each inhibitor at the indicated concentration.
The substrate was then added to the protease inhibitor solution and
the volume was adjusted to 500 Wl with 50 mM Tris-HCl, 20 mM
CaCl2, pH 8.0 bu¡er.
2.5. Determination of inhibition constants
The Lineweaver-Burk representation (1/v = f(1/[s])) is a current
method to determine inhibition constants:
Ki  iK 0m
Km
31
 
However, when using high a⁄nity inhibitors, a deviation between
theoretical and experimental curves appears. Consequently, three oth-
er representations, which are more speci¢c for high a⁄nity inhibitors,
were used: the Dixon (1/v = f([i])), the Henderson ([i]t/[13(vi/v0)] = f(v0/
vi)) and the Dixon (v = f([i])) representations.
3. Results and discussion
3.1. Puri¢cation of mutant trypsin
Mutant trypsin was separated from the other molecules of
periplasmic extract by cation exchange chromatography (Fig.
2A). The drop of pH from 4.0 to 2.0 allowed the dissociation
of the trypsin/ecotin complex (ecotin is an inhibitor of trypsin,
secreted by E. coli, present in the periplasmic extract). Trypsin
collected in the non-retained fractions (as determined from the
zymogram) was further puri¢ed by a⁄nity chromatography
on benzamidine-Sepharose (Fig. 2B). Aliquots of 100 Wl were
kept frozen at 320‡C until use.
3.2. Active site titration
MUGB reacts irreversibly with a 1:1 stoichiometry with the
Ser-195 of the catalytic site of trypsin. This reaction induces
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Fig. 2. A: Cation exchange chromatography on CM-Sepharose of periplasmic extract. Solid line: absorbance at 280 nm; dashed line: NaCl
molarity; dotted line: pH. Inset: Zymogram of fractions 1^4 (a lack of coloration is observed at a level corresponding to the molecular weight
of trypsin). See Section 2 for conditions. B: A⁄nity chromatography on benzamidine-Sepharose.
Table 1
Active site concentrations of trypsins
Enzyme Wild-type K188D/D189K K188F K188Y K188W K188H WFYa
Active site (nM) 55 27 53 48 56 81 22
aWFY: G187W/K188F/D189Y.
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the formation of a trypsin/guanidinobenzoate complex and
the release of 4-methylumbelliferone which is a £uorescent
compound. The £uorometer was calibrated with a bovine
trypsin solution, the concentration of which was in excess,
in such a way that all the molecules of MUGB were hydro-
lyzed. The active site concentrations of mutant trypsins are
given in Table 1.
3.3. Inhibition constants
Inhibitors enter into competition with the speci¢c substrates
of trypsin. More precisely, they decrease the enzyme a⁄nity
for their substrates, increasing the Michaelis-Menten constant
(Km). The inhibition constant is de¢ned as the equilibrium
existing between inhibitor and enzyme.
The determination of Ki is a very important step for the
characterization of inhibiting activity of inhibitors. Several
methods of calculation exist. The Lineweaver-Burk represen-
tation in the presence of inhibitor (PSTI II and BPTI) loses
the linear part of the curve for low concentrations in substrate
(data not shown). According to Morrisson [40], such a type of
curve in the presence of inhibitor is characteristic of a high
a⁄nity inhibitor.
The inhibition of mutant K188F is shown in Fig. 3A,B.
Lost linearity of the representation v0=f([i]) [41] for a strong
inhibitor concentration is proof that these inhibitors are very
speci¢c (Fig. 3B).
Since the inhibitors studied have high a⁄nity for mutant
trypsins, the fraction of inhibitors bound to enzyme is impor-
tant in comparison with the whole concentration of inhibitor.
Consequently, the Morrisson equations were used because
they show the e¡ect of very speci¢c inhibitors on the initial
velocities of hydrolysis. The determination of Ki according to
Henderson derives from the Morrisson equations. The equa-
tions, making it possible to plot the second Dixon represen-
tation (Fig. 3B), take the concentration of bound inhibitor
into account. Thus, they can be applied to competitive high
a⁄nity inhibitors.
The reaction of inhibition is strictly competitive when the
enzyme activity is inhibited totally by the formed enzyme-in-
hibitor complex [42]. The competitive inhibitors behave as
highly speci¢c substrates of the enzymes they inhibit. How-
ever, in contrast to enzyme-substrate complexes, which disso-
ciate rapidly, the enzyme-inhibitor complex is highly stable
(KassW108^1013 M31). This complex, maintained by van der
Waals forces and hydrogen bonds, can dissociate releasing
native or modi¢ed inhibitor. Inhibitors are cleaved speci¢cally
between the residues P1 and PP1 (nomenclature of Schechter
and Berger [43]), but the localization of the cleaved site on an
external loop, closed by a disul¢de bridge, allows the modi¢ed
inhibitor to maintain its three-dimensional structure.
From the calculated inhibition constants (Table 2) it can be
concluded that the inhibition of each mutant trypsin by every
studied inhibitor is always very powerful (KiE1037 M). The
bovine inhibitor had a higher a⁄nity for all tested enzymes
than the pea inhibitor. This could be a consequence of the
animal origin of the modi¢ed enzyme (rat anionic trypsin).
This ¢nding raises an interesting question from the nutritional
point of view. It would be worth while to test other trypsin
inhibitors of plant origin. The inhibition constants di¡er ac-
cording to the mutations on the protease (Table 2). Despite
the similarity of the Km, kcat and kcat/Km values of K188H,
K188F and K188Y, the Ki values of K188H and K188F are
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Fig. 3. A: Henderson representation for PSTI II toward K188F. B: Dixon representation for PSTI II toward K188F. Arg = Suc-Ala-Ala-Pro-
Arg-pNa.
Table 2
Inhibition constants and kinetic parameters of trypsins
Enzyme Inhibition constant Kinetic parameters
PSTI II BPTI
Ki (mol/l) Ki (mol/l) Km (WM) kcat (s31) kcat/Km (s31 WM31)
Bovine trypsin 1.3U1039 þ 2.10310 1U10310 þ 2.10311 37.2 þ 4.3 143 þ 2.4 3.85 þ 1.1
Wild-type enzyme 2.0U1039 þ 1.10310 4U10310 þ 2.10311 32.8 þ 7.1 163 þ 31 4.97 þ 1.21
K188D/D189K 1.47U1038 þ 1.1039 not determined 50.8 þ 4.2 4.7 þ 0.1 0.11 þ 0.01
K188F 5.2U1039 þ 1.10310 4U10310 þ 8.10311 55.4 þ 1.3 144 þ 15 2.63 þ 0.31
K188Y 2.4U1038 þ 2.1039 3.3U1039 þ 3.10310 53.4 þ 2.2 114 þ 12 2.14 þ 0.33
K188W 3.5U1038 þ 4.1039 3.7U1039 þ 1.10310 98.0 þ 8.1 58 þ 3 0.59 þ 0.01
K188H 2.1U1038 þ 3.1039 3U10310 þ 8.10311 50.2 þ 4.1 128 þ 3.3 2.56 þ 0.5
G187W/K188F/D189Y 5.0U1038 þ 5.1039 8U10310 þ 5.10311 46.6 þ 6.8 5 þ 0.45 0.11 þ 0.01
Substrate: Suc-Ala-Ala-Pro-Arg-pNa.
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one order of magnitude lower than that of K188Y. Inhibition
of K188H and K188F by PSTI II shows Ki values di¡ering by
a factor of four. Generally, the mutants with Asp in position
189 and K188 substituted by aromatic groups remained
strongly inhibited by both PSTI II and BPTI but it should
be noticed that K188Y was less inhibited by BPTI even
though it presented a kcat/Km value similar to that measured
with K188F. The low catalytic activity of the mutants in
which Asp-189 is substituted made inhibition measurements
di⁄cult in K188D/D189K and G187W/K188F/D189Y. In this
case, inhibition was measured during longer intervals of time.
With a kcat/Km value smaller than that of wild-type enzyme
(45-fold decrease), the K188D/D189K mutant trypsin showed
a Ki value for PSTI II identical with those observed in aro-
matic mutants. In spite of the experimental conditions used,
the determination of Ki values for K188D/D189K inhibition
by BPTI was impossible. The lower inhibition by PSTI II was
observed with the G187W/K188F/D189Y mutant. This mu-
tant has the same kcat/Km value as K188D/D189K but is de-
void of any negative charge in the substrate binding pocket.
In contrast, the inhibition of mutant G187W/K188F/
D189Y by BPTI was roughly equal to that observed with
wild-type enzyme or K188F. In the case of this inhibitor, Ki
values were less discrepant with the values of Km of each
enzyme measured with Suc-Ala-Ala-Pro-Arg-pNa substrate.
The Km value of the K188D/D189K mutant was similar to
that of G187W/K188F/D189Y mutant but, surprisingly, as
stated above, Ki could not be measured in the presence of
BPTI.
Molecular modelling of the substrate binding pocket of
aromatic mutants (Fig. 4) shows that these mutations do
not perturb the binding site structure and thus they do not
prevent substrate or inhibitor ¢xation. The same observations
can be made with the K188H mutant trypsin (data not
shown).
Graf et al. [13] found that D189K is devoid of trypsin
activity but possesses residual chymotryptic activity. BPTI,
with its protruding reactive K15, could be repelled by K189
of the D189K binding pocket. Molecular modelling of the
substrate binding pocket of K188D/D189K mutant shows a
modi¢cation of the pocket structure due to the displacement
of the negative charge of Asp-189C188. This modi¢cation
can force the side chain of the substrate to change its orien-
tation (Fig. 5). Surprisingly, the inhibition of this mutant by
PSTI II is relatively strong in comparison with its kcat/Km
value. It is possible that K188D/D189K could also, like
D189K, possess chymotryptic activity and that its inhibition
by PSTI II is due to the presence in this inhibitor of a separate
reactive site for chymotrypsin. However, K188D/D189K
showed no chymotryptic activity when measured with L-casein
as natural substrate [15].
The disparity between the a⁄nity of two inhibitors is re-
versed and less pronounced in G187W/K188F/D189Y. Molec-
ular modelling of the substrate binding pocket of G187W/
K188F/D189Y mutant is under investigation. With this mu-
tant, K15 of BPTI would not be repelled by Y189 of the
trypsin mutant.
Thus, except for the K188D/D189K mutant, the inhibition
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Fig. 4. Molecular modelling representation of Asp-189 and amino
acid in position 188 of substrate binding pocket for (A) wild-type
enzyme, (B) K188Y, (C) K188F, and (D) K188W mutant trypsins.
The segment 187-188-189 is represented by a ribbon. The model
substrate is in the upper part.
Fig. 5. Molecular modelling representation (A) of substrate binding pocket (dots) of wild-type trypsin (thin lines) and K188D/D189K mutant
(thick lines), in the presence of a tripeptide substrate; (B) of residues 188 and 189 of the substrate binding pocket in wild-type and K188D/
D189K trypsins.
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di¡erences seem to be due to variations of a⁄nity of modi¢ed
enzymes for their substrate (the competitive inhibitors behave
like substrates and are ¢xed in the same place) in comparison
with the wild-type enzyme.
Since the studied inhibitors present a lysyl residue in posi-
tion P1, the reasons why these high a⁄nity inhibitors (PSTI II
and BPTI) are not good substrates are not completely under-
stood [44^47].
In order to decrease or eliminate the antinutritional quality
of these inhibitors, it is of interest to follow their catabolism
by the di¡erent mutant trypsins.
Previous results obtained by hydrolysis of L-casein by the
aromatic mutants showed that they are able to cleave peptide
bonds involving Asn and Gln residues. This may be interest-
ing since inhibitors are often rich in amide residues.
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